News Sentiment

KNSA sentiment intelligence

Kiniksa Pharmaceuticals Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 60 Balanced news tone 28 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 63.44 Week of 10 Jul 2026
Weighted tone 60/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 28

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-1.7% over one week, +22.3% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Kiniksa Pharmaceuticals: Leader In Pericarditis Merits Hold Rating After Recent Gains

Market Reaction

Balanced read

71/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -1.7% Price digesting
Trend fit Trend active 22.3% over four weeks
Fair value 123.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 14
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 28
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 7
simplywall.st 4
MarketBeat 3
GuruFocus 3
Ad Hoc News 3
Stock Titan 3
Seeking Alpha 1
Simply Wall St. 1

Event Lens

What the news is about

Classified themes
Market update 20
Analyst action 5
Earnings 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-28 of 28